184 related articles for article (PubMed ID: 30411045)
1. Discovery of the Orally Effective Thyrotropin-Releasing Hormone Mimetic: 1-{
Kobayashi N; Sato N; Fujimura Y; Kihara T; Sugita K; Takahashi K; Koike K; Sugawara T; Tada Y; Nakai H; Yoshikawa T
ACS Omega; 2018 Oct; 3(10):13647-13666. PubMed ID: 30411045
[TBL] [Abstract][Full Text] [Related]
2. Correction to Discovery of the Orally Effective Thyrotropin-Releasing Hormone Mimetic: 1-{
Kobayashi N; Sato N; Fujimura Y; Kihara T; Sugita K; Takahashi K; Koike K; Sugawara T; Tada Y; Nakai H; Yoshikawa T
ACS Omega; 2019 Apr; 4(4):6977-6978. PubMed ID: 31459810
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and Evaluation of in Vivo Anti-hypothermic Effect of the N- and C-Terminus Modified Thyrotropin-Releasing Hormone Mimetic: [(4S,5S)-(5-Methyl-2-oxooxazolidine-4-yl)carbonyl]-[3-(thiazol-4-yl)-L-alanyl]-L-prolinamide.
Kobayashi N; Sato N; Sugita K; Kihara T; Koike K; Sugawara T; Tada Y; Yoshikawa T
Chem Pharm Bull (Tokyo); 2021; 69(4):314-324. PubMed ID: 33790077
[TBL] [Abstract][Full Text] [Related]
4. Effect of rovatirelin, a novel thyrotropin-releasing hormone analog, on the central noradrenergic system.
Ijiro T; Nakamura K; Ogata M; Inada H; Kiguchi S; Maruyama K; Nabekura J; Kobayashi M; Ishibashi H
Eur J Pharmacol; 2015 Aug; 761():413-22. PubMed ID: 26142830
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and evaluation of in vivo anti-hypothermic effect of all stereoisomers of the thyrotropin-releasing hormone mimetic: Rovatirelin Hydrate.
Kobayashi N; Sato N; Sugita K; Takahashi K; Sugawara T; Tada Y; Yoshikawa T
J Pept Sci; 2019 Dec; 25(12):e3228. PubMed ID: 31713944
[TBL] [Abstract][Full Text] [Related]
6. Non-clinical pharmacokinetic profiles of rovatirelin, an orally available thyrotropin-releasing hormone analogue.
Kobayashi K; Abe Y; Harada H; Oota E; Endo T; Takeda H
Xenobiotica; 2019 Jan; 49(1):106-119. PubMed ID: 29300135
[TBL] [Abstract][Full Text] [Related]
7. Effects of the novel thyrotropin-releasing hormone analogue Na -((1S,2R)-2-methyl-4-oxocyclopentylcarbonyl)-L-histidyl-L-prol ina mide monohydrate on the central nervous system in mice and rats.
Matsushita M; Yonemori F; Furukawa N; Ohta A; Toide K; Uchida I; Iwata K
Arzneimittelforschung; 1993 Aug; 43(8):813-7. PubMed ID: 8216433
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of the hyperthermic effect of the novel thyrotropin-releasing hormone analogue Na-((1S,2R)-2-methyl-4-oxocyclopentylcarbonyl)-L-histidyl-L- prolinamide monohydrate in mice with reserpine-induced hypothermia.
Matsushita M; Yonemori F; Ohta A; Iwata K
Arzneimittelforschung; 1995 Jun; 45(6):708-11. PubMed ID: 7646576
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and central nervous system actions of thyrotropin-releasing hormone analogues containing a dihydroorotic acid moiety.
Suzuki M; Sugano H; Matsumoto K; Yamamura M; Ishida R
J Med Chem; 1990 Aug; 33(8):2130-7. PubMed ID: 2115588
[TBL] [Abstract][Full Text] [Related]
10. L-6-ketopiperidine-2-carbonyl-L-leucyl-L-proline amide as a novel thyrotropin releasing hormone analogue with improving effects on impaired central nervous systems functions.
Oka M; Ochi Y; Furukawa K; Ito T; Miura Y; Karasawa T; Kadokawa T
Arzneimittelforschung; 1989 Mar; 39(3):297-303. PubMed ID: 2547386
[TBL] [Abstract][Full Text] [Related]
11. [Synthesis and pharmacological action of TRH analog peptide (Taltirelin)].
Yamamura M; Suzuki M; Matsumoto K
Nihon Yakurigaku Zasshi; 1997 Oct; 110 Suppl 1():33P-38P. PubMed ID: 9503402
[TBL] [Abstract][Full Text] [Related]
12. Diversity of thyrotropin-releasing hormone receptors in the pituitary and discrete brain regions of rats.
Asai H; Kinoshita K; Yamamura M; Matsuoka Y
Jpn J Pharmacol; 1999 Mar; 79(3):313-7. PubMed ID: 10230859
[TBL] [Abstract][Full Text] [Related]
13. Rovatirelin ameliorates motor dysfunction in the cytosine arabinoside-induced rat model of spinocerebellar degeneration via acetylcholine and dopamine neurotransmission.
Ijiro T; Yaguchi A; Yokoyama A; Kiguchi S
Clin Exp Pharmacol Physiol; 2022 Sep; 49(9):950-958. PubMed ID: 35637550
[TBL] [Abstract][Full Text] [Related]
14. Discovery of a dual action first-in-class peptide that mimics and enhances CNS-mediated actions of thyrotropin-releasing hormone.
Scalabrino GA; Hogan N; O'Boyle KM; Slator GR; Gregg DJ; Fitchett CM; Draper SM; Bennett GW; Hinkle PM; Bauer K; Williams CH; Tipton KF; Kelly JA
Neuropharmacology; 2007 Jun; 52(7):1472-81. PubMed ID: 17418282
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological study of TA-0910, a new thyrotropin-releasing hormone (TRH) analog, (I): Effects on the central nervous system by oral administration.
Yamamura M; Kinoshita K; Nakagawa H; Tanaka T; Maeda K; Ishida R
Jpn J Pharmacol; 1990 Aug; 53(4):451-61. PubMed ID: 2120494
[TBL] [Abstract][Full Text] [Related]
16. Lack of behavioral tolerance by repeated treatment with taltirelin hydrate, a thyrotropin-releasing hormone analog, in rats.
Asai H; Asahi T; Yamamura M; Yamauchi-Kohno R; Saito A
Pharmacol Biochem Behav; 2005 Dec; 82(4):646-51. PubMed ID: 16368129
[TBL] [Abstract][Full Text] [Related]
17. Effects of thyrotropin-releasing hormone (TRH) on the actions of pentobarbital and other centrally acting drugs.
Breese GR; Cott JM; Cooper BR; Prange AJ; Lipton MA; Plotnikoff NP
J Pharmacol Exp Ther; 1975 Apr; 193(1):11-22. PubMed ID: 805836
[TBL] [Abstract][Full Text] [Related]
18. Gamma-butyrolactone-gamma-carbonyl-histidyl-prolinamide citrate (DN-1417): a novel TRH analog with potent effects on the central nervous system.
Miyamoto M; Fukuda N; Narumi S; Nagai Y; Saji Y; Nagawa Y
Life Sci; 1981 Feb; 28(8):861-9. PubMed ID: 6783804
[No Abstract] [Full Text] [Related]
19. Effects of TA-0910, a novel orally active thyrotropin-releasing hormone analog, on the gait of ataxic animals.
Kinoshita K; Fujitsuka T; Yamamura M; Matsuoka Y
Eur J Pharmacol; 1995 Feb; 274(1-3):65-72. PubMed ID: 7768282
[TBL] [Abstract][Full Text] [Related]
20. Antagonizing effects of YM-14673, a new TRH derivative, on behavioral and electroencephalographic changes in reserpinized animals.
Yamamoto M; Shimizu M; Iwai A
Psychopharmacology (Berl); 1988; 95(2):162-6. PubMed ID: 3137591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
